(Q43704830)

26 November 2017

title

Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century (English)

1 reference

26 November 2017

1 reference

1 reference

Lina Jansen

2

0 references

Alexander Katalinic

Alexander Katalinic

6

0 references

Hermann Brenner

Hermann Brenner

7

0 references

Bernd Holleczek

5

Bernd Holleczek

1 reference

26 November 2017

4

Katharina Emrich

1 reference

GEKID Cancer Survival Working Group

26 November 2017

8

GEKID Cancer Survival Working Group

1 reference

26 November 2017

3

Adam Gondos

1 reference

26 November 2017

1

Dianne Pulte

1 reference

26 November 2017

publication date

3 December 2012

1 reference

26 November 2017

1 reference

26 November 2017

volume

54

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

979-985

1 reference

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Improving relative survival, but large remaining differences in survival for non-Hodgkin's lymphoma across Europe and the United States from 1990 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Survival from common and rare cancers in Germany in the early 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Projecting SEER cancer survival rates to the US: an ecological regression approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Up-to-date and precise estimates of cancer patient survival: model-based period analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

A computer program for period analysis of cancer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

The epidemiology of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Bendamustine: rebirth of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Ongoing Improvement in Outcomes for Patients Diagnosed as Having Non-Hodgkin Lymphoma From the 1990s to the Early 21st Century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Up-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

Deriving Valid Population-Based Cancer Survival Estimates in the Presence of Nonnegligible Proportions of Cancers Notified by Death Certificates Only

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.734616

10.3109/10428194.2012.734616

21 January 2018

Identifiers

DOI

1 reference

release_zldpgid4nbgf5de7nvkfs6vpca

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zldpgid4nbgf5de7nvkfs6vpca

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference